Home > EASL recommendations on treatment of Hepatitis C 2018.

European Association for the Study of the Liver. (2018) EASL recommendations on treatment of Hepatitis C 2018. Elsevier. Journal of Hepatology, 69 (2) 461-11. DOI: https://doi.org/10.1016/j.jhep.2018.03.026

URL: https://www.journal-of-hepatology.eu/article/S0168...

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an enhanced understanding of the pathophysiology of the disease, and because of developments in diagnostic procedures and improvements in therapy and prevention. These European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Alcohol, Alcohol or other drugs in general
Intervention Type:AOD disorder, AOD disorder harm reduction
Date:August 2018
Pages:461-11
Publisher:Elsevier
Corporate Creators:European Association for the Study of the Liver
Volume:69
Number:2
EndNote:View
Subjects:A Substance use, abuse, and dependence > Prevalence > Substance use behaviour > Alcohol consumption
B Substances > Alcohol
G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
G Health and disease > Digestive system disorder > Liver disorder
G Health and disease > Digestive system disorder > Liver disorder > Liver cirrhosis
J Health care, prevention and rehabilitation > Patient care management
J Health care, prevention and rehabilitation > Health care delivery
J Health care, prevention and rehabilitation > Health care administration > Health care quality control
N Communication, information and education > Recommendations or guidelines > Practice / clinical guidelines

Repository Staff Only: item control page